The FDA’s weak drug manufacturing oversight is a potentially deadly problem
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut •
conversation
June 23, 2021 • ~9 min
June 23, 2021 • ~9 min
Artisan robots with AI smarts will juggle tasks, choose tools, mix and match recipes and even order materials – all without human help
Custom fabrication involves taking measurements, choosing tools, deciding on sequences of steps and ordering from a menu of materials. AIs under development promise to take humans out of the loop.
Glenn S. Daehn, Professor of Materials Science and Engineering, The Ohio State University •
conversation
June 15, 2021 • ~8 min
June 15, 2021 • ~8 min
Why is the FDA funded in part by the companies it regulates?
The FDA receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?
C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
• conversation
May 13, 2021 • ~10 min
May 13, 2021 • ~10 min
Why Johnson & Johnson throwing out 15 million COVID-19 vaccine doses shouldn't scare you
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
Tinglong Dai, Associate Professor of Operations Management & Business Analytics, Johns Hopkins Carey Business School, Johns Hopkins University School of Nursing •
conversation
April 1, 2021 • ~6 min
April 1, 2021 • ~6 min
/
23